Copaxone and Levemir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Copaxone (glatiramer acetate) and Levemir (insulin detemir recombinant). Common drug interactions include gastrooesophageal reflux disease among females and cerebrovascular accident among males.

The phase IV clinical study analyzes what interactions people have when they take Copaxone and Levemir. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Copaxone?

Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. eHealthMe is studying from 56,931 Copaxone users. Check the latest studies of Copaxone.

What is Levemir?

Levemir has active ingredients of insulin detemir recombinant. It is often used in diabetes. eHealthMe is studying from 13,850 Levemir users. Check the latest studies of Levemir.

On Jul, 18, 2026

12 people who take Copaxone and Levemir together, and have interactions are studied.

What are the common drug interactions of Copaxone and Levemir, by gender? *:

female:

Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hepatic steatosis (fatty liver disease)
Influenza like illness
Injection site erythema (redness at injection site)
Injection site mass
Low density lipoprotein increased (cholesterol increased in blood)
Lumbar spinal stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone)
Oesophageal spasm (contraction of oesophagus)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)

male:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Memory impairment
Arrhythmia (irregular heartbeat)
Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Asthenia (weakness)
Asthma
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Atrioventricular block first degree (heart block first degree)

What are the common drug interactions of Copaxone and Levemir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Diabetes mellitus inadequate control
Diabetic retinopathy (damage to the retina caused by complications of diabetes)
Retinopathy (acute damage to the retina of the eye)

30-39:

n/a

40-49:

n/a

50-59:

Blood urea increased
Chills (felling of cold)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hepatic steatosis (fatty liver disease)
Hypersensitivity
Influenza like illness
Injection site erythema (redness at injection site)
Injection site mass
Low density lipoprotein increased (cholesterol increased in blood)
Lumbar spinal stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone)

60+:

Abdominal distension
Abdominal pain
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Asthenia (weakness)
Asthma
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Atrioventricular block first degree (heart block first degree)
Back pain
Balance disorder
Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)

What are the existing conditions these people have? *

Gait Disturbance: 4 people, 33.33%
Wheezing (a high-pitched whistling sound made while you breath): 2 people, 16.67%
Pain: 2 people, 16.67%
Type 1 Diabetes: 1 person, 8.33%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 8.33%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 8.33%
Metastatic Neoplasm (spreadable cancer tumour): 1 person, 8.33%
Metastases To Bone (cancer spreads to bone): 1 person, 8.33%
Hypersensitivity: 1 person, 8.33%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Copaxone and Levemir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously